Pretzel Therapeutics

Biotech

pretzeltx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
0 granted · 40 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1103Pattern Pharma Inc.—$1.2M
1104ANCHORCHEM LLC——
1105Vault Nano Inc——
1106Pretzel Therapeutics——
1107VAXNEWMO, LLC——
1108EUGIT THERAPEUTICS, INC.——
1109Proximity Biosciences LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 40
  • Compositions And Methods For Treatment Of Cancer And Metabolic Diseaseapplication
  • Modulators Of Mitochondrial Dna Replicationapplication
  • 7-ALKOXYQUINOLINES As Modulators Of Polrmtapplication
  • Quinolines As Modulators Of Polrmtapplication
  • Isoquinolinones as Modulators of POLRMTapplication
  • CHROMEN-2-ONE Modulators Of Polrmtapplication
  • LONP1 Inhibitor Compounds, Uses And Methodsapplication
  • Amino CHROMEN-2-ONE Modulators Of Polrmtapplication
  • Amide-containing LONP1 Inhibitor Compounds, Uses And Methodsapplication
  • LONP1 Inhibitors, Uses And Methodsapplication
  • Heterocycle-containing LONP1 Inhibitor Compounds, Uses And Methodsapplication
  • Isoquinolinones And Quinolinones As Modulators Of Polrmtapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.